SCM
CNTB

Sio Capital Management’s Connect Biopharma Holdings CNTB Stock Holding History

Sio Capital Management’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-597,678
Closed -$519K – 45
2022
Q4 		$519K Hold
597,678
– – 0.19% 37
2022
Q3 		$771K Hold
597,678
– – 0.25% 37
2022
Q2 		$520K Hold
597,678
– – 0.2% 49
2022
Q1 		$1.8M Buy
+597,678
New +$2.52M 0.6% 39

Other funds holding CNTB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Sio Capital Management's CNTB Position: Q1 2023 in Review

Sio Capital Management sold out of Connect Biopharma Holdings (CNTB) in Q1 2023, closing a stake of 597,678 shares — an estimated $519K sold.

Sio Capital Management first reported a position in CNTB in Q1 2022 and held it in 4 quarters. The position peaked at $1.8M in Q1 2022. 16 funds tracked by Wall St. Rank hold CNTB as of Q1 2023.

  • Sio Capital Management reported no remaining Connect Biopharma Holdings position as of Q1 2023 after selling out during the quarter.
  • Sio Capital Management sold 597,678 Connect Biopharma Holdings shares in Q1 2023, an estimated $519K.
  • Sio Capital Management first reported a position in Connect Biopharma Holdings in Q1 2022 and held it in 4 quarters.
  • Sio Capital Management's Connect Biopharma Holdings position peaked at $1.8M in Q1 2022.
  • 16 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2023.

Based on Sio Capital Management's 13F filing for Q1 2023, filed 12 May 2023.